Hahnemann Pharmaceuticals Private Limited

Hahnemann Pharmaceuticals Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24232DL1996PTC080135 Incorporated 14 July 1996 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2024
₹70.46 Lakh
▲ 28% YoY
Net profit · FY 2024
₹37,249
Net margin 0.5%
EBITDA · FY 2024
₹3.62 Lakh
EBITDA margin 5.1%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹4.92 Lakh
Issued & subscribed
Open charges
₹83 Lakh
Secured borrowings
Company age
30 yrs
Est. 1996
Directors on board
3
As per MCA filings

About Hahnemann Pharmaceuticals Private Limited

Data last updated:

Hahnemann Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the alternative and holistic medicine segment of the healthcare sector. It was incorporated on 14 July 1996 and has been in existence for over 30 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1996PTC080135. Its GSTIN is 07AAACH1772R1Z5 (Delhi).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹4.92 Lakh. It is led by directors including Neeru Narula and Pooja Narula.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 7 Naraina Industrial Area Phase – I, New Delhi, Delhi, India – 110028.

As per the financials filed for FY 2024, the company reported a revenue of ₹70.46 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹37,249 (net margin 0.5%) and EBITDA of ₹3.62 Lakh (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 5% over five years.

As per MCA filings, the company has open charges of ₹83 Lakh on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it.

Hahnemann Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0011293). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hahnemannpharma.com.

Company details

CIN U24232DL1996PTC080135
Registration Number 080135
Incorporation Date 14 July 1996
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0011293

Recognitions & Rankings of Hahnemann Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-10-0011293

Contact details

Hahnemann Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is hahnemannpharma.com. Its e-mail address is in the company report.

  • Email
  • Social Media
  • Registered Address
    A – 7 Naraina Industrial Area Phase – I, New Delhi, Delhi, India – 110028
  • Industry
    Healthcare, Alternative & Holistic Medicine

To see the full contact details of Hahnemann Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Hahnemann Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Hahnemann Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Hahnemann Pharmaceuticals Private Limited, buy the company report.

Financials of Hahnemann Pharmaceuticals Private Limited

FY 2025 filings available

Hahnemann Pharmaceuticals Private Limited reported revenue of ₹70.46 Lakh (up 28% YoY) for FY 2024.

Revenue · FY 2024
₹70.46 Lakh ▲ 28%
Net profit · FY 2024
₹37,249 margin 0.5%
EBITDA · FY 2024
₹3.62 Lakh margin 5.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▼ 10%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▼ 26%
5 years · compounded
▲ 33%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 28% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.62 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹37,249
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5.1%
Net Profit Margin0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hahnemann Pharmaceuticals Private Limited, buy the company report.

Board of directors of Hahnemann Pharmaceuticals Private Limited

Hahnemann Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Neeru NarulaDirector14 Jul 199630 Years 3 MonthsCurrent
Karan NarulaAdditional Director02 Sep 20197 Years 2 MonthsCurrent
Pooja NarulaDirector14 Jul 199630 Years 3 MonthsCurrent

Peer comparison

Hahnemann Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vizag Pharmaceuticals Private Limited₹70.81 Lakh (FY 2016)-52.0%Hyderabad, Telangana, India
Ecstatic Pharmaceuticals Private Limited₹70.76 Lakh (FY 2023)13.0%Thane, Maharashtra, India
Physa Pharmaceuticals Private Limited₹70.69 Lakh (FY 2025)8.0%Noida, Uttar Pradesh, India
Hahnemann Pharmaceuticals Private Limitedthis company₹70.46 Lakh (FY 2024)₹37,2490.5%28.0%New Delhi, Delhi, India
Cross Berry Pharmaceuticals Private Limited₹69.6 Lakh (FY 2020)50.0%Kolhapur, Maharashtra, India
Deemar Pharmaceuticals Private Limited₹69.5 Lakh (FY 2025)46233.0%Hyderabad, Telangana, India

To see the full peer comparison of Hahnemann Pharmaceuticals Private Limited, buy the company report.

Auditor

Hahnemann Pharmaceuticals Private Limited is audited by R. Chadha & Associates for the financial year 2017.

Auditor firmFinancial yearFirm registration number
R. Chadha & AssociatesFY 201783135

Shareholding

The shareholding of Hahnemann Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Hahnemann Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹83 Lakh
Satisfied charges
None
Breakdown by lending institutions
Bank of India₹0.53 Cr
The Jammu & Kashmir Bank Ltd.₹0.16 Cr
Union Bank of India₹0.09 Cr
Uco Bank₹0.05 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Mar 200590059013Bank of India₹53 LakhOpen
20 Dec 200290057944The Jammu & Kashmir Bank Ltd.₹16 LakhOpen
06 Jan 200090057164Uco Bank₹5 LakhOpen
11 Sep 199790056749Union Bank of India₹9 LakhOpen

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hahnemann Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Hahnemann Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAACH1772R1Z5DelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Hahnemann Pharmaceuticals Private Limited, buy the company report.

Recent activity

Hahnemann Pharmaceuticals Private Limited has 3 board changes on record since 1996: 3 appointments. The latest: Karan Narula was appointed as Additional Director on 02 Sep 2019.

AGM
Hahnemann Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hahnemann Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Karan Narula was appointed as Additional Director.
Charges
A charge with Bank Of India amounted to Rs. 53.00 Lakh with Charge ID 90059013 was registered on 29 Mar 2005.
Charges
A charge with The Jammu & Kashmir Bank Ltd. amounted to Rs. 16.00 Lakh with Charge ID 90057944 was registered on 20 Dec 2002.
Charges
A charge with Uco Bank amounted to Rs. 5.00 Lakh with Charge ID 90057164 was registered on 06 Jan 2000.
Charges
A charge with Union Bank Of India amounted to Rs. 9.00 Lakh with Charge ID 90056749 was registered on 11 Sep 1997.
Appointed
Neeru Narula was appointed as Director.
Appointed
Pooja Narula was appointed as Director.
Incorporation
14 Jul 1996
Hahnemann Pharmaceuticals Private Limited was registered on 14 Jul 1996 with Roc Delhi & aged 30 years 3 months as per MCA records.

Frequently asked questions

Hahnemann Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in alternative and holistic medicine, within the healthcare industry. It was incorporated on 14 July 1996 (30+ years old) and is registered under CIN U24232DL1996PTC080135.

Hahnemann Pharmaceuticals has 3 current directors:

The latest financial statements of Hahnemann Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Hahnemann Pharmaceuticals is 07AAACH1772R1Z5, registered in Delhi.

The CIN (Corporate Identification Number) of Hahnemann Pharmaceuticals is U24232DL1996PTC080135. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hahnemann Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it.

Hahnemann Pharmaceuticals was incorporated on 14 July 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Hahnemann Pharmaceuticals by revenue are Vizag Pharmaceuticals Private Limited, Ecstatic Pharmaceuticals Private Limited, Physa Pharmaceuticals Private Limited, Cross Berry Pharmaceuticals Private Limited, Deemar Pharmaceuticals Private Limited, all in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Karan Narula was appointed as Additional Director on 02 Sep 2019. Neeru Narula was appointed as Director on 14 Jul 1996. Pooja Narula was appointed as Director on 14 Jul 1996.

Yes, Hahnemann Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0011293).

Hahnemann Pharmaceuticals can be reached through the website hahnemannpharma.com. Its registered office is in New Delhi, Delhi, India.